Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Preparation method of azilsartan intermediate

A technology for intermediates and solid bases, applied in the field of preparation of pharmaceutical compounds, can solve problems such as unfavorable reactions, miscellaneous products, high prices, etc., and achieve the effects of improving yield, low cost, and simple recovery

Active Publication Date: 2014-06-25
SICHUAN OPEN MEDICINE CO LTD
View PDF7 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The catalyst tetrabutylammonium fluoride is expensive, and the one-pot cooking method leads to a very mixed product, which is not conducive to the next reaction

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0044] Take 42.4g (0.61mol) of hydroxylamine hydrochloride, add it to 85ml 95% ethanol, stir, 0-20°C, add 10g of anhydrous sodium sulfate, slowly add 19.45g (0.49mol) of sodium hydroxide, and filter when the reaction system stops exothermic , 25g of compound of formula (II) (0.061mol), 61.5g of triethylamine (0.61mol), 125ml of ethanol were added to the filtrate, refluxed at 75-80°C for 16 hours, cooled to room temperature, and filtered to obtain intermediate compound of formula (I). Body 15.4g. Detected by HPLC: 83.363% of the intermediate of formula (I), 8.784% of the amide.

Embodiment 2

[0046] Take 196.8g (1.2mol) of hydroxylamine sulfate, add it to 420ml 90% ethanol, stir, 0-20°C, add 50g of anhydrous sodium sulfate, slowly add 60.5g (1.08mol) of potassium hydroxide, and filter when the reaction system stops exothermic 125g of the compound of formula (II) (0.3mol), 87.6g of diethylamine (1.2mol), 600ml of ethanol were added to the filtrate, refluxed at 75-80°C for 16 hours, cooled to room temperature, and filtered to obtain the intermediate compound of formula (I). Body 79.0g. Detected by HPLC: 85.741% of the intermediate of formula (I), 7.518% of the amide.

Embodiment 3

[0048] Take 210g (3mol) of hydroxylamine hydrochloride, add it to 420ml 95% ethanol, stir, 0-20°C, add 50g of anhydrous sodium sulfate, slowly add 84g (2.1mol) of sodium hydroxide, filter when the reaction system stops exothermic, the filtrate Add 125g of compound of formula (II) (0.3mol), 310g of triethylamine (3mol), 600ml of ethanol, reflux at 75-80°C for 16 hours, cool to room temperature, and filter to obtain 79.0g of intermediate of formula (I). Detected by HPLC: 86.906% of the intermediate of formula (I), 3.076% of the amide.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a preparation method of an azilsartan intermediate. The preparation method of the azilsartan intermediate comprises the following steps: dissociating hydroxylamine hydrochloride through alkali in ethanol which is 90-95% in mass percentage, filtering, adding a compound as shown in formula (II) in the specification, triethylamine and ethanol to filtrate, implementing a reflux reaction, cooling and crystallizing after the reaction, and filtering to obtain the target intermediate as shown in formula (I). The target intermediate prepared by the preparation method disclosed by the invention is high in content, and low in content of amide impurities, which is generally less than 10%.

Description

technical field [0001] The invention belongs to the preparation of pharmaceutical compounds, in particular to a preparation method of an angiotensin II receptor antagonist azilsartan intermediate. Background technique [0002] Azilsartan is an angiotensin Ⅱ receptor antagonist researched and developed by Takeda Pharmaceutical Co., Ltd., Japan. It can be taken orally as a powerful antihypertensive drug. Its preparation and therapeutic use have been described in the specification of Chinese invention patent CN92105152.2. Among them, the compound of the following formula (I), namely, 2-ethoxy-1-{[((2'-hydroxyaminomethylimino)biphenyl)-4-yl]methyl}-1H-benzimidazole -7-Carboxylic acid is an important intermediate in the synthesis of azilsartan. [0003] (I) [0004] The method for preparing formula (I) compound has been described in detail in document J.Med.chem.1996.Vo39 (26) 5528-5235 and Chinese patent CN92105152.2: take formula (II) compound, i.e. 1-[((2' -Nitrylbipheny...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D235/26
CPCC07D235/26
Inventor 刘波骆俊清魏岚但汉兴刘琳宛燕飞丁昭莉
Owner SICHUAN OPEN MEDICINE CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com